Related Experiment Video
Updated: Dec 14, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in
Zonghui Ding1, Zhiwan Dong2, Yuping Yang2
1Department of Cancer Biology, Mayo Clinic Arizona, Scottsdale, Arizona.
Abstract:
Glioblastoma (GBM) is the most common primary malignant brain cancer in adults. A hallmark of GBM is aggressive invasion of tumor cells into the surrounding normal brain. Both the current standard of care and targeted therapies have largely failed to specifically address this issue. Therefore, identifying key regulators of GBM cell migration and invasion is important. The leukemia-associated Rho guanine nucleotide exchange factor (LARG) has previously been implicated in cell invasion in other tumor types; however, its role in GBM pathobiology remains undefined. Herein, we report that the expression levels of LARG and ras homolog family members C (RhoC), and A (RhoA) increase with glial tumor grade and are highest in GBM. LARG and RhoC protein expression is more prominent in invading cells, whereas RhoA expression is largely restricted to cells in the tumor core. Knockdown of LARG by siRNA inhibits GBM cell migration in vitro and invasion ex vivo in organotypic brain slices. Moreover, siRNA-mediated silencing of RhoC suppresses GBM cell migration in vitro and invasion ex vivo, whereas depletion of RhoA enhances GBM cell migration and invasion, supporting a role for LARG and RhoC in GBM cell migration and invasion. Depletion of LARG increases the sensitivity of GBM cells to temozolomide treatment. Collectively, these results suggest that LARG and RhoC may represent unappreciated targets to inhibit glioma invasion.
Insights
Leukemia-associated Rho guanine nucleotide exchange factor (LARG) and RhoC promote glioblastoma invasion. Inhibiting LARG may also enhance temozolomide treatment effectiveness for brain tumors.
Area of Science:
- Neuro-oncology
- Cancer biology
- Molecular mechanisms of cancer progression
Background:
- Glioblastoma (GBM) is an aggressive brain cancer characterized by invasive tumor cells.
- Current therapies are insufficient to halt GBM invasion.
- Leukemia-associated Rho guanine nucleotide exchange factor (LARG) is implicated in other cancers but its role in GBM is unknown.
Purpose of the Study:
- To investigate the role of LARG and its downstream effectors, RhoC and RhoA, in GBM cell migration and invasion.
- To explore LARG as a potential therapeutic target for inhibiting glioma invasion and enhancing chemotherapy response.
Main Methods:
- Quantitative analysis of LARG, RhoA, and RhoC protein expression in glial tumors of varying grades.
- In vitro and ex vivo assays using siRNA to knockdown LARG, RhoC, and RhoA in GBM cells.
- Assessment of GBM cell migration and invasion following gene silencing.
- Evaluation of temozolomide sensitivity in GBM cells with LARG depletion.
Main Results:
- LARG, RhoC, and RhoA expression increases with glial tumor grade, peaking in GBM.
- LARG and RhoC are predominantly expressed in invading GBM cells.
- LARG and RhoC knockdown inhibits GBM cell migration and invasion.
- RhoA depletion enhances GBM cell migration and invasion.
- LARG depletion sensitizes GBM cells to temozolomide.
Conclusions:
- LARG and RhoC are key regulators of GBM cell invasion.
- Targeting LARG and RhoC may offer a novel strategy to inhibit glioma spread.
- LARG inhibition could potentiate the efficacy of standard chemotherapy for glioblastoma.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Cell Polarization by Rho Proteins
GTPases and their Regulation
Large G-proteins,...
Cancer Cell Migration through Invadopodia
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

